532P The changes of the serum SMRP levels is useful to predict the antitumor efficacy of ipilimumab plus nivolumab combination therapy in patients with malignant pleural mesothelioma

Autor: Otsuki, T., Kawamura, N., Murakami, M., Kondo, T., Fujioka, T., Morishita, M., Tokuda, M., Higashiyama, T., Tada, A., Negi, Y., Horio, D., Mikami, K., Takahashi, R., Minami, T., Kuribayashi, K., Kijima, T.
Zdroj: In Annals of Oncology November 2023 34 Supplement 4:S1677-S1677
Databáze: ScienceDirect